Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Technological Approaches for Improving Vaccination Compliance and Coverage
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Technological Approaches for Improving Vaccination Compliance and Coverage
Creator
Milicic, Anita
Gamian, Andrzej
Guyon, Romain
Górska, Sabina
Ilić, Tanja
Krajišnik, Danina
Lavelle, Ed
Lemoine, Céline
Longet, Stephanie
Nikolić, Ines
Pantelić, Ivana
Razim, Agnieszka
Savić, Snežana
Thakur, Aneesh
topic
covid:dc06cca0afc9bb476a589c6e8bf1453dd5520aa2#this
Source
Medline; PMC
abstract
Vaccination has been well recognised as a critically important tool in preventing infectious disease, yet incomplete immunisation coverage remains a major obstacle to achieving disease control and eradication. As medical products for global access, vaccines need to be safe, effective and inexpensive. In line with these goals, continuous improvements of vaccine delivery strategies are necessary to achieve the full potential of immunisation. Novel technologies related to vaccine delivery and route of administration, use of advanced adjuvants and controlled antigen release (single-dose immunisation) approaches are expected to contribute to improved coverage and patient compliance. This review discusses the application of micro- and nano-technologies in the alternative routes of vaccine administration (mucosal and cutaneous vaccination), oral vaccine delivery as well as vaccine encapsulation with the aim of controlled antigen release for single-dose vaccination.
has issue date
2020-06-16
(
xsd:dateTime
)
bibo:doi
10.3390/vaccines8020304
bibo:pmid
32560088
has license
cc-by
sha1sum (hex)
dc06cca0afc9bb476a589c6e8bf1453dd5520aa2
schema:url
https://doi.org/10.3390/vaccines8020304
resource representing a document's title
Technological Approaches for Improving Vaccination Compliance and Coverage
has PubMed Central identifier
PMC7350210
has PubMed identifier
32560088
schema:publication
Vaccines (Basel)
resource representing a document's body
covid:dc06cca0afc9bb476a589c6e8bf1453dd5520aa2#body_text
is
http://vocab.deri.ie/void#inDataset
of
https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/dc06cca0afc9bb476a589c6e8bf1453dd5520aa2
is
schema:about
of
named entity 'route'
named entity 'release'
named entity 'strategies'
named entity 'routes'
named entity 'global'
named entity 'improved'
named entity 'advanced'
named entity 'VACCINE ADMINISTRATION'
named entity 'GOALS'
named entity 'NOVEL'
named entity 'AIM'
named entity 'ENCAPSULATION'
named entity 'COVERAGE'
named entity 'TECHNOLOGIES'
covid:arg/dc06cca0afc9bb476a589c6e8bf1453dd5520aa2
named entity 'continuous'
named entity 'expected'
named entity 'improvements'
named entity 'Novel'
named entity 'vaccine'
named entity 'oral vaccine'
named entity 'adjuvants'
named entity 'antigen'
named entity 'infectious disease'
named entity 'vaccine delivery'
named entity 'Vaccination'
named entity 'Vaccination'
named entity 'antigen'
named entity 'natural killer'
named entity 'chitosan'
named entity 'immune response'
named entity 'oral vaccine'
named entity 'animal models'
named entity 'microscale'
named entity 'delivery systems'
named entity 'pneumococcal'
named entity 'microcapsules'
named entity 'integrins'
named entity 'APCs'
named entity 'cervical cancer'
named entity 'intradermal'
named entity 'vaccine'
named entity 'DNA vaccine'
named entity 'microfluidics'
named entity 'inhalable'
named entity 'L-fucose'
named entity 'microfluidic'
named entity 'immunisation'
named entity 'pathogens'
named entity 'microfluidic'
named entity 'antibody'
named entity 'meningitis'
named entity 'drug delivery'
named entity 'polymer'
named entity 'miscible'
named entity 'heat stability'
named entity 'polymer'
named entity 'TLR9'
named entity 'capillary'
named entity 'vaccination'
named entity 'antigen'
named entity 'immunisation'
named entity 'vaccine delivery'
named entity 'fluid flow'
named entity 'pre-clinical'
named entity 'drug delivery'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 14
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software